Trials / Unknown
UnknownNCT04609345
Prevalence of Ocular Surface Disease in Malaysian Glaucoma Patients
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 400 (estimated)
- Sponsor
- Santen Pharma Malaysia Sdn Bhd · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective, multi-centre, cross sectional observational study to determine the prevalence of ocular surface disease (OSD) in glaucoma patients, nationwide. The study also analyses sub group of OSD prevalence, stratified according to the treatment types (i.e. preserved, preservative-free, and combination of preservative-free and preserved eyedrops), and illustrates the patient perspective on OSD.
Detailed description
For this prospective, multi-centre, cross sectional observational study, patients who attend routine eye examination at the medical institutions and who have been diagnosed with primary open-angle glaucoma, primary angle-closure glaucoma, pseudoexfoliation glaucoma, pigment dispersion glaucoma or ocular hypertension will be studied. The medical institutions are selected across different regions of Malaysia to assess the nationwide prevalence of OSD in glaucoma patients. The routine assessments include Corneal Evaluation, Tear Break-Up Time (TBUT), Hyperemia and Schirmer's test whereby the data from these assessments will be collected and analyzed. The study will also includes Symptom Evaluation and Questionnaire feedback.
Conditions
- Primary Open-angle Glaucoma
- Primary Angle-Closure Glaucoma
- Pseudoexfoliation Glaucoma
- Pigment Dispersion Glaucoma
- Ocular Hypertension
Timeline
- Start date
- 2020-11-01
- Primary completion
- 2021-04-01
- Completion
- 2021-05-01
- First posted
- 2020-10-30
- Last updated
- 2020-10-30
Source: ClinicalTrials.gov record NCT04609345. Inclusion in this directory is not an endorsement.